ValueAct Capital Management, LLC
CIK 1351073 · last filed 2023-11-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
STX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, 4TH FLOOR
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRM | Director | 3,487,972 | $242.21 | $844.80M | $0 | 1 | 2023-11-27 |
| CBRE | Director | 5,837,748 | $122.67 | $716.15M | -$2.20B | 1 | 2023-08-03 |
| NSIT | Director | 4,511,116 | $178.80 | $806.59M | $106.74M | 2 | 2023-05-18 |
| LKQ | Director | 12,552,751 | $17.07 | $214.21M | -$1.76B | 1 | 2022-05-19 |
| STX | Director | 17,380,812 | $674.30 | $11.72B | -$4.13B | 6 | 2021-10-22 |
| BHC | Director | 16,993,250 | $6.25 | $106.29M | $0 | 2 | 2020-05-01 |
| TRN | Director | 27,005,855 | $25.20 | $680.55M | $337.44M | 4 | 2020-03-06 |
| AES | Director | 1,564,500 | $15.03 | $23.51M | $0 | 2 | 2019-04-22 |
| AWI | Director | 4,622,681 | $153.22 | $708.29M | $0 | 3 | 2018-06-06 |
| FOXA | Director | 53,326,334 | $64.23 | $3.43B | $0 | 3 | 2018-04-20 |
| WILLIS TOWERS WATSON PLC (WLTW) Delisted | Director | 2,246,770 | $231.56 | $520.26M | -$1.89B | 6 | 2017-11-13 |
| MSFT | Director | 2,380,168 | $532.13 | $1.27B | -$2.38B | 4 | 2017-02-23 |
| BREAD FINANCIAL HOLDINGS, INC. (ADS) Delisted | 10%+ Owner | 5,634,900 | $56.80 | $320.06M | $287.86M | 1 | 2017-01-25 |
| MSCI | Director | 475,900 | $605.61 | $288.21M | -$1.29B | 4 | 2016-09-16 |
| ALSN | Director | 19,128,432 | $106.56 | $2.04B | $61.84M | 5 | 2016-05-16 |
| ADBE | Director | 9,661,127 | $250.63 | $2.42B | -$1.33B | 2 | 2016-03-23 |
| CBRE GROUP, INC. (CBG) Delisted | Director | 32,157,667 | — | — | -$50.70M | 3 | 2014-11-03 |
| WILLIS TOWERS WATSON PLC (WSH) Delisted | Director | 6,956,367 | — | — | $0 | 1 | 2014-08-13 |
| OPENLANE, Inc. (KAR) Delisted | Director | 803,628 | $30.88 | $24.82M | -$470.67M | 3 | 2013-09-26 |
| IT | Director | 2,355,402 | $224.03 | $527.68M | -$161.87M | 1 | 2011-12-05 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | 10%+ Owner | 0 | — | — | $77.73M | 5 | 2010-09-30 |
| IMMUCOR INC (BLUD) Delisted | 10%+ Owner | 7,440,665 | — | — | $23.59M | 1 | 2010-06-02 |
| LiveRamp Holdings, Inc. (ACXM) Delisted | 10%+ Owner | 8,876,342 | — | — | -$5.40M | 1 | 2008-11-07 |
| SLE | 10%+ Owner | 665 | $5.41 | $3.6K | $0 | 1 | 2008-08-28 |
| PRA International (PRAI) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2007-06-13 |
| SIRVA INC (SIR) Delisted | Director | — | — | — | $0 | 2 | 2007-04-04 |
Recent Filings · Page 8 of 8
80 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-06-04 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,800,000 | $41.96M | EDGAR |
| 2008-11-07 | LiveRamp Holdings, Inc. (ACXM) Delisted | Sell (S) | −699,170 | -$5.40M | EDGAR |
| 2008-10-17 | — | Other (J) | — | $0 | |
| 2008-08-28 | SLE | Grant (A) | +28,872 | $390.1K | EDGAR |
| 2007-12-21 | — | Other (J) | −51,406,578 | $0 | |
| 2007-10-03 | — | Other (J) | −36,230,500 | -$1.18B | |
| 2007-06-13 | PRA International (PRAI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-04-04 | SIRVA INC (SIR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-02-16 | — | Other (J) | −256,465,060 | $0 | |
| 2007-01-05 | SIRVA INC (SIR) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.